CHAIR:
 |
Beth Faiman Cleveland Clinic Taussig Cancer Institute Dr. Faiman has become an exemplary leader in bringing critical knowledge of cancer nursing to clinical providers – locally, nationally, and internationally. As a founding member of the International Myeloma Foundation Nurse Leadership Board (NLB) and practicing clinician, she demonstrates enthusiasm for continuous learning by conducting innovative research and demonstrates the importance of using and integrating new medical knowledge within nursing practices. In 2023, Faiman was given the NP/PA Educator of Distinction Award in Multiple Myeloma and in 2022, Faiman was named the Top NP in Hematology/Oncology and inducted as an inaugural Fellow of Advanced Practice in Oncology (FAPO) awarded by the Advanced Practitioner Society for Hematology and Oncology (APSHO). Faiman is a Distinguished Fellow in the American Academy of Nursing (FAAN). She is the current Editor-in-Chief of Journal of the Advanced Practitioner in Oncology. She remains an active author, presenter, mentor, and educator on the topics of hematology, oncology and supportive cancer care. Dr. Faiman received her Bachelor of Science in Nursing degree from Ursuline Academy (1996), a Master of Science in Nursing at Kent State University (2002), and a PhD in clinical research from Case Western Reserve University (2014). Faiman is an adult nurse practitioner in the Department of Hematology/Oncology at the Cleveland Clinic in Ohio, and a clinical member of the Case Comprehensive Cancer Center under the Cancer Prevention, Control and Population Research Program. She has edited several books and authored many chapters and papers, including Editor of the 3rd Edition of the Multiple Myeloma Textbook for Nurses (2021), and both Editions of the Blood and Marrow Certification Manual for Nurses (2017, 2023), by ONS publishing. She previously held appointments on the American Board of Internal Medicine and American Society of Hematology. Dr. Faiman is thrilled to return to ONS as Chair of the 18th IMF Nurse Leadership Board Symposium in 2024. |
FACULTY:
 |
Kevin Brigle Massey Comprehensive Cancer Center Kevin E. Brigle, PhD, NP, earned his Bachelor of Science Degree in Biology from the University of Dayton followed by a PhD in Molecular Microbiology from Virginia Tech. While consulting on an NIH-funded grant in the School of Nursing, Dr. Brigle was inspired to enroll in the adult nurse practitioner program at VCU and graduated in 1998. He currently holds a position as an Oncology Nurse Practitioner in the Myeloma, Amyloid and MGUS clinic at the NCI-designated Massey Comprehensive Cancer Center at the Virginia Commonwealth University Health System, taking care of patients with myeloma treated on both standard therapies and on clinical trials. Dr. Brigle has served as a member of the International Myeloma Foundation’s Nurse Leadership Board (NLB) since 2015, working to improve the nursing- and self-care of patients with myeloma. In his role on the NLB, Dr. Brigle has made valuable contributions to the education of both patients and nurses through educational seminars across the country. Additionally, he was an author of the NLB’s recent JADPRO supplement, “Multiple Myeloma and Plasma Cell Disorders: A 2022 Update on Diagnosis, Prognosis, Treatment and Supportive Care.” Dr. Brigle is adjunct faculty in the School of Nursing and has authored or co-authored 29 peer-reviewed journal articles and 9 book chapters. In his 20 years as an oncology nurse practitioner, he has been named the Distinguished Practitioner of the Year in the state of Virginia, he has been honored with the ONS Pearl Moore “Making a Difference” Emerging Leader Award, and he has been appointed by the governor as a member of the Advisory Committee to the Virginia Joint Boards of Medicine and Nursing.
|
 |
Donna D. Catamero Mount Sinai Health System Donna Catamero received a Bachelor of Science in nursing from Simmons College in 2002 and her Master of Science in nursing from NYU in 2010. For 20 years, Ms. Catamero has been involved in clinical research. She worked as a Nurse Practitioner in the Multiple Myeloma Program at New York University Langone Medical Center in New York City and later at Mount Sinai, also in New York City, until 2018. Then Ms. Catamero spent two years in industry working as Scientific Director of Medical Affairs in multiple myeloma where she developed expertise in both BCMA research and education development for healthcare providers. She is now back at Mount Sinai where she serves as Associate Director of Myeloma Research. In this position, she oversees clinical research projects and develops standards of care for professional practice. In addition to her clinical and administrative roles, Donna is adjunct faculty in the Mount Sinai Phillips School of Nursing. Ms. Catamero is an active author, presenter, and educator including co-authoring “On the Horizon,” the concluding chapter in Multiple Myeloma: A Textbook for Nurses (3rd ed.) addressing the rapidly changing landscape of myeloma. Having worked on the frontlines during the initial COVID surge in New York City, among her many publications was a timely article on “Considerations of COVID-19–Specific Myeloma Guidelines in New York City.” Ms. Catamero has recently presented for the JADPRO Roundtable and for Myeloma Australia. Ms. Catamero is deeply devoted to her patients, including personal efforts to raise awareness and funds for myeloma research. Ms. Catamero first joined the IMF Nurse Leadership Board (NLB) in 2014, and the NLB considers themselves fortunate to have her back. She has served as a chairperson for roundtables and advisory boards, appears in IMF’s Myeloma University, and is a co-author on the forthcoming JADPRO article, “Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action.” Ms. Catamero embraces the opportunity to assist the NLB in its mission to work with both nurses and patients to improve the lives of those with multiple myeloma.
|
 |
Patricia A. Mangan Abramson Cancer Center Patricia A. Mangan, RN, MSN, APRN-BC, is Nurse Lead of the Hematologic Malignancies and Stem Cell Transplant Programs at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia. University of Pennsylvania is a world-renowned institution with a highly sought after practice in myeloma. They initiated the first clinical trials of CAR-T cell therapy, marking a significant milestone in personalized cellular therapy for cancer and establishing Penn as a leading institution in Car-T Cell therapy. Ms. Mangan works in collaborative practice with Edward A. Stadtmauer, MD, focusing on the care of patients with multiple myeloma and other blood cancers. She is also a Clinical Academic Associate at the University of Pennsylvania’s School of Nursing. Ms. Mangan has served as the nurse liaison of the Multiple Myeloma Committee and the Bone Marrow Transplant Committee of the Eastern Cooperative Oncology Group. She is a member of the Nursing Leadership Board of the International Myeloma Foundation. Ms. Mangan earned her Master of Science in Nursing degree from the University of Pennsylvania and is a board-certified registered nurse practitioner (CRNP) and clinical nurse specialist. Ms. Mangan is a highly sought after speaker on a broad number of topics that deal with bone marrow transplant and the care of patients with hematologic malignancies, and particularly regarding cellular therapy. Patricia Mangan has lectured on both the local and national level, and is engaged in research from clinical trials to patient outcomes and perceptions. The results of her work have appeared in such peer-reviewed journals as Blood, Nursing, Bone Marrow Transplant, Clinical Journal of the Oncology Nursing Society (CJON), The Lancet Haematology and The Nurse Practitioner. As a founding member of the IMF Nurse Leadership Board, Ms. Mangan is looking forward to the 20th meeting of this prolific group of expert nurses. She is delighted to return to ONS as a speaker at the IMF Nurse Leadership Board Symposium this year. |